135 related articles for article (PubMed ID: 4628156)
21. Experiences in the development of plasma derivatives in Japan.
Naito R
Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047
[No Abstract] [Full Text] [Related]
22. Fractionation of plasma with polyethylene glycol.
Polson A; Ruiz-Bravo C
Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
[No Abstract] [Full Text] [Related]
23. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of albumin?
Barker LF; Cazal P; Haussman HG; Hollán S; Kellner A; Lundsgaard-Hansen P; Schiff P
Vox Sang; 1976; 31?-73(3):225-38. PubMed ID: 969394
[No Abstract] [Full Text] [Related]
24. [Use of the albumin from fibrinolyzed blood in producing sera for determining the rhesus factor by an express method].
Donskov SI
Probl Gematol Pereliv Krovi; 1973 Aug; 18(8):54-5. PubMed ID: 4205590
[No Abstract] [Full Text] [Related]
25. Plasma fractionation in blood transfusion service.
Haskó F; Salamon M; Bartha K; Dobó P
Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
[TBL] [Abstract][Full Text] [Related]
26. [Blood products and plasma derivatives].
Faber JC
Bull Soc Sci Med Grand Duche Luxemb; 1988; 125(2):45-53. PubMed ID: 3242960
[No Abstract] [Full Text] [Related]
27. Note for guidance. Guidelines for medicinal products derived from human blood and plasma. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
Biologicals; 1992 Jun; 20(2):159-64. PubMed ID: 1389112
[No Abstract] [Full Text] [Related]
28. Advances in plasmatic fractions used in blood transfusion.
Hollan SR
Rev Fr Transfus Immunohematol; 1979 Feb; 22(1):17-33. PubMed ID: 386471
[TBL] [Abstract][Full Text] [Related]
29. [Studies on enzyme activity in the human placenta during normal and disturbed pregnancy. VI. Alkaline and acid phosphatase during disturbed pregnancy].
Székeley JA; Hahn V
Zentralbl Gynakol; 1970 Jun; 92(24):773-8. PubMed ID: 4997978
[No Abstract] [Full Text] [Related]
30. Round table discussion on plasma fractionation.
Vox Sang; 1972; 23(1):61-5. PubMed ID: 5081015
[No Abstract] [Full Text] [Related]
31. New trends in plasma fractionation and plasma products.
Burnouf T
Vox Sang; 1994; 67 Suppl 3():251-3. PubMed ID: 7975504
[No Abstract] [Full Text] [Related]
32. Blood component therapy in neonatal medicine.
Lenes BA; Sacher RA
Clin Lab Med; 1981 Jun; 1(2):285-309. PubMed ID: 6809397
[No Abstract] [Full Text] [Related]
33. [Therapeutic use of hemoderivatives].
Yurrebaso Eguilior N; Mota Villaplana FM; Montoro Ronsano JB
Sangre (Barc); 1997 Oct; 42(5):423-7. PubMed ID: 9424747
[No Abstract] [Full Text] [Related]
34. [Current therapy with blood and blood derivatives].
Gelabert A; Puig L; Mazzara R
Med Clin (Barc); 1983 Apr; 80(12):550-9. PubMed ID: 6345950
[No Abstract] [Full Text] [Related]
35. The development of plasma derivatives for clinical use. A symposium summary.
Deutsch HF
Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010
[No Abstract] [Full Text] [Related]
36. [Preparation of human albumin from hemolysed blood from frozen placental extracts. II. Elimination of certain impurities during purification].
Pla J; Liautaud J; Debrus A; Gattel P; Plan R; Peyron L
Dev Biol Stand; 1974; 27():115-22. PubMed ID: 4218989
[No Abstract] [Full Text] [Related]
37. [A specific radioimmunologic assay for human placental alkaline phosphatase and its clinical applications].
Hayer M; Guennec JY; Magnan de Bornier B
Pathol Biol (Paris); 1984 Nov; 32(9):938-44. PubMed ID: 6504571
[TBL] [Abstract][Full Text] [Related]
38. [Replacing the administration of whole blood with blood derivatives].
Baklaja R
Bilt Hematol Transfuz; 1982; 10(2-3):115-29. PubMed ID: 6927292
[No Abstract] [Full Text] [Related]
39. Which is the foreseeable future role of ethanol fractionation for the production of the main fractions albumin and immunoglobulins, as well as for the preparation of concentrates of trace proteins like coagulation factors? What is the evidence for a superior performance and practicability of other manufacturing procedures?
Vox Sang; 1981 Jan; 40(1):48-63. PubMed ID: 6784343
[No Abstract] [Full Text] [Related]
40. [New aspects of therapy with blood and blood components].
Frick U; Frick G
Zentralbl Chir; 1983; 108(23):1478-84. PubMed ID: 6666422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
